A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine

NCT00390676 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: ADH -1 and carboplatin
DRUG: ADH -1 and docetaxel
DRUG: ADH -1 and capecitabine

Sponsor

Adherex Technologies, Inc.

Collaborators

[object Object]